| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |